Schembri, Mark http://orcid.org/0000-0002-3611-2771
Verbaan, Dagmar
Emmer, Bart J.
Coert, Bert A.
Majoie, Charles B. L. M.
Vandertop, W. Peter
van den Berg, René
Article History
Received: 24 February 2021
Accepted: 6 June 2021
First Online: 14 July 2021
Declarations
:
: The Medical Research Involving Human Subjects Act does not apply to this study and therefore an approval of the Institutional Medical Ethics Review Committee was not necessary.
: For this type of study, formal consent is not required.
: No identifying data was included in the current study.
: RvdB reports a consultancy agreement with Cerenovus neurovascular outside the submitted work (paid to institution). CBLMM reports grants from TWIN, during the conduct of the study, and grants from CVON/Dutch Heart Foundation, European Commission, Dutch Health Evaluation Program, and from Stryker outside the submitted work (paid to institution) and is a shareholder of Nico-lab. All other authors did not receive support from any organization for the submitted work, had no financial relationships with any organizations that might have an interest in the submitted work in the previous three years, and had no other relationships or activities that could appear to have influenced the submitted work.